Oberland Capital
North America, New York, United States, New York
Description
Oberland Capital provides innovative financing solutions to companies .
Investor Profile
Oberland Capital has backed more than 16 startups, with 5 new investments in the last 12 months alone. The firm has led 15 rounds, about 94% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Post Ipo Debt, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Denmark, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
- Led 5 rounds in the past year.
Stage Focus
- Post Ipo Equity (38%)
- Post Ipo Debt (38%)
- Series Unknown (13%)
- Series A (6%)
- Debt Financing (6%)
Country Focus
- United States (88%)
- Denmark (6%)
- Switzerland (6%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Therapeutics
- Health Diagnostics
- Biopharma
- Medical
- Hospital
- Medical Device
- Emergency Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
